Open AccessS221: BORTEZOMIB TO R‐DHAP COMPARED TO R‐DHAP IN RELAPSED/REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA ELIGIBLE TO STEM CELL TRANPLANTATION: FINAL RESULTS OF PHASE II RANDOMIZED FIL‐VERAL12
Author(s) -
Chiappella A.,
Balzarotti M.,
Botto B,
Castiglione A.,
Cavallo F.,
Usai S. V.,
Zanni M.,
Califano C.,
Re F.,
Ghiggi C.,
Olivieri A.,
Corradini P.,
Liberati A. M.,
Volpetti S.,
Michieli M. G.,
Tucci A,
Gaidano G.,
Tani M.,
Ciambelli F.,
Musuraca G.,
Vallisa D.,
Merli F.,
Molinari A. L.,
Tafuri A.,
Zilioli V. R.,
Marino D.,
Stelitano C.,
Pileri S. A.,
Ciccone G.,
Vitolo U.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000843776.08811.17
Subject(s) - dhap , medicine , bortezomib , autologous stem cell transplantation , oncology , regimen , cytarabine , transplantation , surgery , chemotherapy , multiple myeloma , chemistry , biochemistry , enzyme